Abstract
Excessive stimulation of NMDA receptors is involved in various CNS pathologies such as Parkinsons disease, acute and chronic pain and cerebral ischaemia. The use of NMDA antagonists as therapeutic agents has been restricted as a result of unwanted side effects including hallucinations and loss of co-ordination. NR2B subtype selective antagonists have previously shown a therapeutic effect without causing the side effects of broad spectrum NMDA antagonists. Considerable research has since been devoted to the development of orally bioavailable, selective NR2B antagonists and their applications in various neurological diseases. The improved therapeutic index of these compounds is expected to be the result of the subtype selectivity and cellular location of the NR2B receptors within the CNS. This review describes recent advances in the development of NR2B antagonists as well as their therapeutic applications.
Keywords: NR2B, Antagonist, NMDA receptors, Neurological disease, CNS, Structure-activity relationships, NR2B Selective Antagonists, metabotropic glutamate, dysphoria, extrasynaptically, extrasynaptic NR2B, pharmacokinetics, ifenprodil pharmacophore, 3,4-difluoro-substitution, Various Cinnamidines, phenylpropyl subunit, naphthamidine, cinnamidine-based NR2B, Pharmacokinetic Data, 4-trifluoromethoxy, hyperalgesia, autoradiography, cinnamidines, trifluoromethoxyphenyl, aforementioned, SAfiRs, pharmacokinetic, repolarization, rigidification, piperidines, NMDA antagonists, antinociceptive, Kynurenic Acid Amides, 7-hydroxy analogue, discriminate, thiadiazolyl, Aminoheterocycle Derivatives, carageenan-induced, anti-nociceptive effects, allodynia, cyclohexane, Heterocycles, Cyclohexanol Phenols, cyclohexane derivatives, mousepartial-sciatic-nerve-ligation, 4-dihydroquinolinon, lipophilic, Aniline, Enantiomeric Propanolamines, Tahirovic, enantiomeric propranolamines, 4-methylsulfonamide, isobutyl, enantioselectivity, hydroxyl group, Propanolamines, discrimination, homopiperidine, Heterocyclic, thiosemicarbazide, Ethylenediamine, Affinities, noradrenalin, excitotoxicity, NEUROLOGICAL, L-DOPA therapy, anti-Parkinsonian effects, sensorimotor, Immunocytochemical, Ifenprodil, neuroprotective effects, Huntington's Disease, neurodegeneration, Alzheimer's Disease, glutamate, psychomimetic, epileptiform, intraperitoneal, paroxysmal disorder, polycyclic units, in vivo evaluation
Current Medicinal Chemistry
Title: Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists
Volume: 17 Issue: 34
Author(s): C. Beinat, S. Banister, I. Moussa, A. J. Reynolds, C. S.P. McErlean and M. Kassiou
Affiliation:
Keywords: NR2B, Antagonist, NMDA receptors, Neurological disease, CNS, Structure-activity relationships, NR2B Selective Antagonists, metabotropic glutamate, dysphoria, extrasynaptically, extrasynaptic NR2B, pharmacokinetics, ifenprodil pharmacophore, 3,4-difluoro-substitution, Various Cinnamidines, phenylpropyl subunit, naphthamidine, cinnamidine-based NR2B, Pharmacokinetic Data, 4-trifluoromethoxy, hyperalgesia, autoradiography, cinnamidines, trifluoromethoxyphenyl, aforementioned, SAfiRs, pharmacokinetic, repolarization, rigidification, piperidines, NMDA antagonists, antinociceptive, Kynurenic Acid Amides, 7-hydroxy analogue, discriminate, thiadiazolyl, Aminoheterocycle Derivatives, carageenan-induced, anti-nociceptive effects, allodynia, cyclohexane, Heterocycles, Cyclohexanol Phenols, cyclohexane derivatives, mousepartial-sciatic-nerve-ligation, 4-dihydroquinolinon, lipophilic, Aniline, Enantiomeric Propanolamines, Tahirovic, enantiomeric propranolamines, 4-methylsulfonamide, isobutyl, enantioselectivity, hydroxyl group, Propanolamines, discrimination, homopiperidine, Heterocyclic, thiosemicarbazide, Ethylenediamine, Affinities, noradrenalin, excitotoxicity, NEUROLOGICAL, L-DOPA therapy, anti-Parkinsonian effects, sensorimotor, Immunocytochemical, Ifenprodil, neuroprotective effects, Huntington's Disease, neurodegeneration, Alzheimer's Disease, glutamate, psychomimetic, epileptiform, intraperitoneal, paroxysmal disorder, polycyclic units, in vivo evaluation
Abstract: Excessive stimulation of NMDA receptors is involved in various CNS pathologies such as Parkinsons disease, acute and chronic pain and cerebral ischaemia. The use of NMDA antagonists as therapeutic agents has been restricted as a result of unwanted side effects including hallucinations and loss of co-ordination. NR2B subtype selective antagonists have previously shown a therapeutic effect without causing the side effects of broad spectrum NMDA antagonists. Considerable research has since been devoted to the development of orally bioavailable, selective NR2B antagonists and their applications in various neurological diseases. The improved therapeutic index of these compounds is expected to be the result of the subtype selectivity and cellular location of the NR2B receptors within the CNS. This review describes recent advances in the development of NR2B antagonists as well as their therapeutic applications.
Export Options
About this article
Cite this article as:
Beinat C., Banister S., Moussa I., J. Reynolds A., S.P. McErlean C. and Kassiou M., Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists, Current Medicinal Chemistry 2010; 17 (34) . https://dx.doi.org/10.2174/092986710793348572
DOI https://dx.doi.org/10.2174/092986710793348572 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued) Fluorescent Probes for Cellular Assays
Combinatorial Chemistry & High Throughput Screening Recent Software Developments and Applications in Functional Imaging
Current Pharmaceutical Biotechnology The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Current Drug Metabolism The Role of Spiritual Health Experience with Intensity and Duration of Labor Pain While Childbearing and Postpartum
Current Women`s Health Reviews Organotypic Brain Slices of ADULT Transgenic Mice: A Tool to Study Alzheimer’s Disease
Current Alzheimer Research Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Current Pharmaceutical Design Hematologic Abnormalities in the Antiphospholipid Syndrome
Current Rheumatology Reviews Synthesis and Pharmacological Screening of Novel 1,3-Disubstituted 5-Pyrazolones as Anticonvulsant Agents
Current Bioactive Compounds The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation
Current Pharmaceutical Design Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure
CNS & Neurological Disorders - Drug Targets Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats
CNS & Neurological Disorders - Drug Targets Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Molecular Docking, Synthesis and CNS Activity of Some Novel 1, 4-Benzodiazepine Derivatives
Letters in Drug Design & Discovery Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
Current Genomics Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer’s Diseases and its Pathological Mechanisms
Current Molecular Medicine Sodium Valproate Induced Tremor in a Patient with Epilepsy and Down's Syndrome
Current Drug Safety